Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues:        
Total revenues $ 38,406 $ 25,453 $ 73,746 $ 43,485
Costs and operating expenses:        
Cost of product revenue 11,270 4,318 19,791 8,536
Research and development 19,089 12,826 38,590 24,397
Selling, general and administrative 10,656 12,795 26,360 24,193
Total costs and operating expenses 41,015 29,939 84,741 57,126
Loss from operations (2,609) (4,486) (10,995) (13,641)
Interest income 140 206 182 382
Other income (expense), net (63) 23 (66) (63)
Loss before income taxes (2,532) (4,257) (10,879) (13,322)
Provision for income taxes 108 8 117 11
Net loss $ (2,640) $ (4,265) $ (10,996) $ (13,333)
Net loss per share, basic (usd per share) $ (0.04) $ (0.07) $ (0.17) $ (0.21)
Net loss per share, diluted (usd per share) $ (0.04) $ (0.07) $ (0.17) $ (0.21)
Weighted average common stock shares used in computing net income (loss) per share, basic (shares) 65,288 64,434 65,193 64,363
Weighted average common stock shares used in computing net income (loss) per share, diluted (shares) 65,288 64,434 65,193 64,363
Product revenue        
Revenues:        
Total revenues $ 34,645 $ 14,717 $ 65,335 $ 24,943
Research and development revenue        
Revenues:        
Total revenues $ 3,761 $ 10,736 $ 8,411 $ 18,542